Medine.co.uk

Gaviscon Advance Mint Chewable Tablets

Document: leaflet MAH BRAND_PL 00063-0613 change

:----------i-------------1---'    '---i----------

PATIENT INFORIV^ATION LEAFLET I GAVISC([)N ADVANCE MINT CHEWABEE TABLETS |    i    Sodium alginate

i    | Potassium bicarbonate |

[Please read this leaflet carefully before you take this medicine. If prou are not su(e about anything ^sk your pharmacist or doctor.

^Vhat are Gaviscon Advance Mint Chewable Tablets?

Gaviscon Advance Mint Chewable [Tablets belong to a group of medicines calleji ‘reflux suppressants’, which form a protective layer bn top of the stomach contents to prevent stomach acid escaping from [the stomach where it works into the food pipe causing pain and discomfort.    [    [    [

^Vhat are Gaviscon Advance Mint Chewable Tablets used for?

Gaviscon Advance Mint Chewable [Tablets are used for! the treatment of symptoms of[ gastro-oesophagea) reflux such as acid[ regurgitation, heartburn and indigestion, which may occur, for example, following (neals or during pregnancy, and in patients with symptoms related to oesophagitis.    [    [    [

it can also be used to relieve the symptoms of conditions such as hiatus hernia (protrusion of muscle ithrough a muscle wall), symptoms of hoarseness a(id other voice disorders, sore throat an<j cough associated with [reflux. It can be tak[en to control heartblum symptoms [which may occur while taking, or following withdrawal of medication to reduce stomalch acid such as Proton Pump Inhibitors! (PPI’s) or H2 Antagonists.    [    [    [

[Before using tiaviscon Advance Mint Chewable Tablets:

Do not take this product if:    [    [

i* You know yoji are allergic to any[ of the ingredients ^s very rarely [ difficulty in breathing and skin rashes have occurred'(see further [ information for a full list of ingredients).    !

[Take special csjre before treatment with Gaviscon Advance Mint phewable Tablets:

This medicine contains sodium (4.3 mmol per two-tablpt dose), potassium (2.0 (nmol per two-table) dose) and calcium [(2.0 mmol per (wo-tablet dose}.    |    |

[• If you have been advised to follow a diet restricted in any of these i salts please consult your doctor Ijefore taking this product.

[• Please also talk to your doctor regarding these salt contents if you [ suffer or have suffered from significant kidney or heart disease, as | certain salts cjould interfere with these diseases. [

[If you have phenylketonuria, note that this product is sweetened with aspartame, a source of phenylalanine.    !


Please consult your doctor if you kjiow you have reduced amounts of [ gastric acid in your stomach, as thi) product may be le^s effective. [

'Taking other medicines    [    [    [

[Please tell your doctor or pharmacis) if you are taking or[have recently [ [taken any other medicines, including medicines obtained without [prescription,    i    i    i    i

[Pregnancy and[ breast-feeding:    [

[You can take this product if you are pregnant or breast- feeding. As with' [all medicines, tHe treatment duration should be limited as much as [ possible.    [    [    [    [

[How to take Gaviscon Advance Mint Chewable Tablets:

[For oral administration. Chew thoroughly before swallowing.    [

Adults and children over 12 yearsj When symptoms o([cur take one to [ (wo tablets after meals and at bedtime.    '    '

[Children under 12 years: Should only he taken on medical advice.    !

I    1    1    11

,If you forget a dose it is not necessary to double the dose next time, just ' 'carry on taking as before.    i    i    i

[    i    i    ii

,If you take too much of this product you may feel bloated. It is unlikely ' to cause you any harm, but please consult your doctor or! pharmacist.    !

I    I    II

After taking Gaviscon Advance M)nt Chewable Tablets:    [

[If symptoms persist after 7 days consult your doctor.    j

'Possible side effects    [    [    [

[Very rarely (les^ than 1 in 10,000 parents treated), there [is chance of an [ [allergic reaction to the ingredients. Symptoms of this may include skin ' rash, difficulty ip breathing, dizziness, or swelling of the, face, lips,    !

tongue or throat[ If you experience tjiese or any other sidp-efifects stop [ [taking the product and consult your doctor or pharmacist.

[Also you can hejlp to make sure that [medicines remain a^ safe as    [

[possible by reporting any unwanted side effects via the internet at ' [http://www.mhra.gov.uk/yellowcardi    i    i

'Alternatively yc|u can call Freephon) 0808 100 3352 (available from [ [10 a.m. to 2 p.m. Mondays to Fridays) or fill in a paper form available ' [from your local pharmacy.

[storing your ipedicine:    [    [    [

[Do not use after the expiry date (EXP month/year) shown on the pack. 1 KEEP OUT Otf THE REACH ANb SIGHT OF CHILDREN.

Do not store abcjve 30°C. Store in th]e original package. [    [

[Further information    '    '    '

[Gaviscon Advance Mint Chewable 'tablets are off-white [to cream,    !

circular, flat witp bevelled edges tablets with the odour a[nd flavour of [ [peppermint. Each tablet contains sodium alginate 500 mg and potassium [ [bicarbonate lOOimg as the active ingredients.    i    i

!_________J____________L___________'    __8083637


The otherThgretJients are mannitol (p42I)( calcium carbonate) macrogol £0,000, magnesium stearate, aspartame (E951), mint flavour, acesulfame potassium, copovidone.

these tablets do not contain sugar or gluten.


Gaviscon Advance Mint Chewable tablets are available [12’s & 24’s.    '


in pack sizes of


Manufacturer and PL Holder:

(Leckitt Benckiser Healthcare (UK) Limited, Dansom Lane, Hull, [HU8 7DS. [

paviscon and (|) are trade marks, text revised: February 2013


.[___.80B3637